Partial splenic embolization in myelodysplastic syndrome associated with immune thrombocytopenia
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, vol.18, no.3, pp.213-216, 2005 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 18 Issue: 3
- Publication Date: 2005
- Doi Number: 10.1007/s11239-005-0349-2
- Journal Name: JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.213-216
- Çukurova University Affiliated: No
Abstract
Backround: Currently, all treatments for patients with myelodysplastic syndrome (MDS) are still experimental. Supportive care, including treatment of infection and transfusion of blood and blood-related products, remains the most important aspect of therapy in these cases. This article discusses the results of partial splenic embolization in a patient who had MDS with refractory anemia.